|
|
|
Volumn 8, Issue 1, 2001, Pages 167-171
|
|
Cisplatin, mitomycin-C, 5-fluorouracil and leucovorin combination chemotherapy (l-FCM) in locally advanced unresectable or metastatic gastric carcinoma: A phase-II study
|
|
Author keywords
5 FU; Chemotherapy; Cisplatin; Gastric cancer; Leucovorin; Mitomycin c; Tolerability
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CISPLATIN;
FLMP PROTOCOL;
FLUOROURACIL;
FOLINIC ACID;
MITOMYCIN;
ADULT;
AGED;
ALOPECIA;
ARTICLE;
CARCINOMA;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
DRUG ADMINISTRATION;
FEMALE;
HEMATOLOGIC DISEASE;
HUMAN;
KIDNEY DISEASE;
LIFE TABLE;
MALE;
MIDDLE AGED;
MORTALITY;
MULTICENTER STUDY;
PATHOLOGY;
PHASE 2 CLINICAL TRIAL;
SALVAGE THERAPY;
STOMACH TUMOR;
SURVIVAL;
TREATMENT OUTCOME;
ADULT;
AGED;
ALOPECIA;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA;
CISPLATIN;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
FLUOROURACIL;
HEMATOLOGIC DISEASES;
HUMANS;
KIDNEY DISEASES;
LEUCOVORIN;
LIFE TABLES;
MALE;
MIDDLE AGED;
MITOMYCIN;
SALVAGE THERAPY;
STOMACH NEOPLASMS;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
|
|
EID: 0035227062
PISSN: 1021335X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (4)
|
|
References (3)
|
